Study Published in Antimicrobial Agents and Chemotherapy Finds Antifungal Compound VT-1598 Developed by Mycovia Pharmaceuticals Demonstrates In Vitro and In Vivo Activity Against Deadly Candida Auris Fungus

200

DURHAM, N.C.–(BUSINESS WIRE)–Published Study Finds Mycovia’s Antifungal Compound VT-1598 Demonstrates In Vitro and In Vivo Activity Against Deadly Candida Auris Fungus http://www.businesswire.com/news/home/20190411005541/en/Study-Published-Antimicrobial-Agents-Chemotherapy-Finds-Antifungal/?feedref=JjAwJuNHiystnCoBq_hl-QyNsUQ29c24MKpwrFSKUOTZQK86VRF04E6aMvZHPoaH7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LP6oD-t3eB0qV-nJQ-WeFyCEq7XOd8em_Uy42DWNTo2Mw==